IRIS Accounts Productionv26.1.10.61OtherCompany accountsTruefalsePounds1.1.2531.12.2531.12.25FYFRS 102Independent examinerSmall companies regime for accountsFullCharities SORPtruetruetruetruefalsetruefalsetrue iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh096729702024-12-31096729702025-12-31096729702025-01-012025-12-31096729702023-12-31096729702024-01-012024-12-31096729702024-12-3109672970ns0:CharitableCompanyLimitedByGuarantee2025-01-012025-12-3109672970ns15:PoundSterling2025-01-012025-12-3109672970ns11:FRS1022025-01-012025-12-3109672970ns0:IndependentExaminationCharity2025-01-012025-12-3109672970ns11:SmallCompaniesRegimeForAccounts2025-01-012025-12-3109672970ns11:FullAccounts2025-01-012025-12-3109672970ns0:CharitiesSORP2025-01-012025-12-3109672970ns16:EnglandWales2025-01-012025-12-3109672970ns11:RegisteredOffice2025-01-012025-12-3109672970ns0:Trustee12025-01-012025-12-3109672970ns0:Trustee22025-01-012025-12-3109672970ns0:Trustee32025-01-012025-12-3109672970ns0:Trustee42025-01-012025-12-3109672970ns0:Trustee52025-01-012025-12-3109672970ns11:CompanySecretary12025-01-012025-12-3109672970ns0:TotalUnrestrictedFunds2025-01-012025-12-3109672970ns0:TotalRestrictedIncomeFunds2025-01-012025-12-3109672970ns0:Activity82025-01-012025-12-3109672970ns0:Activity8ns0:TotalUnrestrictedFunds2025-01-012025-12-3109672970ns0:Activity8ns0:TotalRestrictedIncomeFunds2025-01-012025-12-3109672970ns0:Activity82024-01-012024-12-3109672970ns0:TotalUnrestrictedFunds2024-12-3109672970ns0:TotalRestrictedIncomeFunds2024-12-3109672970ns0:TotalUnrestrictedFunds2025-12-3109672970ns0:TotalRestrictedIncomeFunds2025-12-3109672970ns0:TotalUnrestrictedFundsns10:WithinOneYear2025-12-3109672970ns0:TotalRestrictedIncomeFundsns10:WithinOneYear2025-12-3109672970ns10:WithinOneYear2025-12-3109672970ns10:WithinOneYear2024-12-310967297022025-01-012025-12-310967297032025-01-012025-12-3109672970ns0:TotalUnrestrictedFunds2024-01-012024-12-3109672970ns0:TotalRestrictedIncomeFunds2024-01-012024-12-3109672970ns0:Activity8ns0:TotalUnrestrictedFunds2024-01-012024-12-3109672970ns0:Activity8ns0:TotalRestrictedIncomeFunds2024-01-012024-12-31

REGISTERED COMPANY NUMBER: 09672970 (England and Wales)

REGISTERED CHARITY NUMBER: 1163152


















REPORT OF THE TRUSTEES AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025


FOR



THE NATIONAL FEDERATION OF PROSTATE
CANCER SUPPORT GROUPS



THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025












Page




Report of the Trustees  

1


to


5



Independent Examiner's Report  

6


to


7



Statement of Financial Activities  

8




Balance Sheet  

9


to


10



Notes to the Financial Statements  

11


to


16



THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS (REGISTERED NUMBER: 09672970)



REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2025




Six years ago, Tackle operated without employees. Today, the charity has a small professional team working alongside a dedicated network of volunteers and support group leaders. Together, they support a national community of people living with and affected by prostate cancer.


During 2025, the charity continued to strengthen its core offer, expand its reach, and launch new programmes designed to support individuals at critical moments in their diagnosis and treatment journey.


OBJECTIVES AND ACTIVITIES

Purpose and Public Benefit

Tackle Prostate Cancer exists to support people living with and affected by prostate cancer through peer support, shared knowledge and collective advocacy.

The charity delivers public benefit by:
- Reducing isolation through peer-led support groups
- Providing access to lived experience and practical guidance
- Amplifying patient voices to influence services and policy
- Supporting volunteers to deliver safe, sustainable community support

The Trustees confirm they have complied with their duty to have due regard to the Charity Commission's public benefit guidance



THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS (REGISTERED NUMBER: 09672970)



REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2025



OBJECTIVES AND ACTIVITIES

Achievements and Performance

STRENGTHENING THE PEER SUPPORT NETWORK

Supporting and developing prostate cancer support groups remains the central focus of Tackle's work. During 2025 the charity continued to strengthen its national network of groups, providing guidance, resources and practical support to volunteer leaders across the UK. New groups were established in several areas and emerging groups were supported to develop sustainable leadership and governance arrangements. The charity also continued to provide opportunities for support group leaders to connect with one another, share learning and discuss challenges through national meetings and engagement with the central team, including EDI training in collaboration with PCUK.

Alongside day-to-day support, resources were developed to help groups strengthen their organisational resilience, including guidance on safeguarding, leadership succession and governance.

These activities ensure that support groups remain welcoming, sustainable and able to meet the needs of people living with and affected by prostate cancer within their communities.

DEVELOPING PEER COACHING SUPPORT

A major milestone during the year was the launch of the Make Sense of It peer coaching programme, funded by Movember.

This programme supports people newly diagnosed with prostate cancer by connecting them with trained volunteers who have lived experience. It provides reassurance, improves understanding of treatment options and helps individuals feel supported at a critical time.

During 2025, the charity established the programme's foundations, including recruitment, training, safeguarding frameworks and delivery infrastructure.

STRENGTHENING COMMUNICATIONS AND AWARENESS

During the year, Tackle refreshed its website to improve accessibility and better reflect its national offer. This resulted in a significant increase in engagement, demonstrating that more people are finding and accessing support.

The charity also developed the Many Faces of Prostate Cancer storytelling project, helping to share lived experiences and reflect the diversity of people affected.

Communications work focused on meaningful engagement and trust-building rather than headline metrics, supporting long-term awareness and connection.

CAMPAIGNING AND ADVOCACY

Tackle continued to ensure that the voices of people living with and affected by prostate cancer are represented in national discussions.

This was very clearly demonstrated by a collaboration with Prostate Cancer Research (PCR) to lobby The National Screening Committee during its deliberations on the future of prostate cancer screening. Initially debated by Conference, leaders encouraged group members to lobby MPs and decision makers. In the aftermath of the draft decision, Tackle worked with PCR, being co-signatories of their report questioning the validity of the draft findings.

The charity engaged with parliamentarians through the All-Party Parliamentary Group on Prostate Cancer and collaborated with sector partners to contribute to conversations around diagnosis, treatment and inequalities.




THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS (REGISTERED NUMBER: 09672970)



REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2025



OBJECTIVES AND ACTIVITIES

Much of this advocacy is driven by the lived experiences of support group members, ensuring that patient voices remain central to service development.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Tackle Prostate Cancer is governed by a Board of Trustees responsible for the charity's strategic direction and oversight.

The Trustees bring a combination of professional expertise and lived experience. The charity is supported by a small staff team working closely with volunteers and support group leaders.

Future plans

The charity will continue to build on its progress in 2025 with a focus on:
- Expanding the Make Sense of It peer coaching programme
- Strengthening and growing the support group network
- Increasing awareness of peer support
- Improving accessibility for diverse communities
- Strengthening partnerships across the sector
- Strengthening The Board to work towards long term financial sustainability.

Through this work, Tackle will continue to ensure that everyone living with and affected by prostate cancer has access to support, information and community.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The National Federation of Prostate Cancer Support Groups (operating under the name: Tackle Prostate Cancer) is a charitable company limited by guarantee, incorporated on 6 July 2015, and registered as a charity on 14 August 2015. On 1 January 2016, The National Federation of Prostate Cancer Support Groups acquired the whole of the assets and liabilities of the unincorporated association Prostate Cancer Support Federation (PCSF). PCSF had been formed in September 2007 and was dissolved in February 2016. The company was set up under a memorandum and Articles of Association (Articles) which set up the objects, powers, and governance of the company. These Articles were revised and adopted by special resolution on 6 February 2023.


Recruitment and appointment of new trustees

The Board consists of not less than three nor more than eleven Directors made up as follows:

- Up to seven Directors being members of member organisations and elected by the members at the Annual General Meeting
- Up to four Directors appointed by the Board who have specific expertise e.g., finance, HR, or marketing; and
- The Directors shall appoint one of their number as Chair and may determine the length of term to serve in that office. The Directors may also appoint one of their number as vice-chair.

Directors are also Trustees of the charity and govern the activities of the Charity as a Board. Upon appointment to the Board, to help ease their understanding of the current issues concerning the organisation, each new Director is provided with a copy of the Charity Commission publication entitled "The Essential Trustee: What you need to know" which gives guidance on what is expected of them. New Directors are also provided with briefings from the Chair on the structure, strategy and operations of the charity. The Board meets four times a year and devolves responsibility for overseeing the day-to-day running of the organisation to the executive team currently led by Sarah Gray and overseen by the Chair and Vice-Chair. Sub-committees with Trustee representation is in place to govern specific activities such as finance, fundraising, marketing, appointments and remuneration.



THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS (REGISTERED NUMBER: 09672970)



REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2025



STRUCTURE, GOVERNANCE AND MANAGEMENT

The purpose of the charity

The charity is a federation, whose member organisations ("members") are patient-led prostate cancer support groups. The purpose of the charity is to co-ordinate, focus and strengthen the efforts of prostate cancer patients in general, and its member organisations specifically, in their cause to alleviate the plight of those affected by prostate cancer.

Objectives and activities for the public benefit

As set out in its governing document, the objects of the charity are to relieve the sickness, physical and mental distress of persons affected by prostate cancer in the UK, but not exclusively by:

1. assisting and strengthening the activities in support of people affected by prostate cancer, including encouraging and supporting the formation of new local prostate support organisations throughout the UK
2. encouraging the improvement of health services available to prostate cancer patients; and
3. acting as a focus for and expressing the views of patient-led support groups concerning
a. raising awareness of prostate cancer
b. improving the health services available to prostate cancer patients; and
c. priorities for research into the diagnosis and treatment of prostate cancer.

Our vision is to be the 'go to' charity for peer support and our mission is to enable the growth of peer support groups across the country, ensuring the needs of people living with and impacted by prostate cancer are met, and their voices heard.

Our strategic imperatives as set out in our 3-year plan (2023-2026) are to:

- Grow and strengthen our relationships and reputation amongst peer support groups
- Recognise and amplify the importance of the user voice across the health and social care system
- Demonstrate our impact and value to the prostate cancer community and general public
- Secure financial sustainability through an effective fundraising strategy
- Ensure we have robust organisational governance to deliver our strategy and mandatory requirements

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Company number

09672970 (England and Wales)


Registered Charity number

1163152


Registered office

Todmorden Community College

Burnely Road

Todmorden

OL14 7BX


Trustees

P P Davies Trustee, Chair (appointed 31.3.26)

C R Perera Trustee, Chair (resigned 31.3.26)

A F C Collier BEM Trustee, Vice Chair

D Wardell Trustee

F I Chinegwundoh MBE Medical Doctor

P N Corbishley Trustee

K Mastris Director

J G Eloket Trustee

J Hill Trustee

S Smith Trustee




THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS (REGISTERED NUMBER: 09672970)



REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 DECEMBER 2025



REFERENCE AND ADMINISTRATIVE DETAILS

Company Secretary

D Wardell


Independent Examiner

TGFP

Chartered Accountants

Fulford House

Newbold Terrace

Leamington Spa

Warwickshire

CV32 4EA


Bankers

NatWest

Liverpool Street Station (B) Branch

PO Box 282

216 Bishopgate

London

EC2M 4QB


Approved by order of the board of trustees on 9 July 2026 and signed on its behalf by:






P P Davies - Trustee


INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF

THE NATIONAL FEDERATION OF PROSTATE

CANCER SUPPORT GROUPS



Independent examiner's report to the trustees of The National Federation Of Prostate Cancer Support Groups ('the Company')

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2025.


Responsibilities and basis of report

As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').


Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.


Independent examiner's statement

Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.


I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:


1.

accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or

2.

the accounts do not accord with those records; or

3.

the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or

4.

the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).


I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.



INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF

THE NATIONAL FEDERATION OF PROSTATE

CANCER SUPPORT GROUPS


Basis of independent examiner's report


My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below.









BENJAMIN R REYNOLDS BSc (Hons) FCA.


TGFP

Chartered Accountants

Fulford House

Newbold Terrace

Leamington Spa

Warwickshire

CV32 4EA


9 July 2026



THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



STATEMENT OF FINANCIAL ACTIVITIES

FOR THE YEAR ENDED 31 DECEMBER 2025



2025


2024


Unrestricted


Restricted


Total


Total


funds


funds


funds


funds


Notes

£   

£   

£   

£   


INCOME AND ENDOWMENTS FROM

Donations and legacies

130,802


283,133


413,935


178,633



Investment income

2

6,492


-


6,492


595


Total

137,294


283,133


420,427


179,228



EXPENDITURE ON

Raising funds

29,072


-


29,072


25,152



Charitable activities

3

Charitable activities

59,276


190,116


249,392


176,637


Total

88,348


190,116


278,464


201,789



NET INCOME/(EXPENDITURE)

48,946


93,017


141,963


(22,561

)

Transfers between funds

10

46,261


(46,261

)

-


-


Net movement in funds

95,207


46,756


141,963


(22,561

)


RECONCILIATION OF FUNDS

Total funds brought forward

84,034


57,497


141,531


164,092



TOTAL FUNDS CARRIED FORWARD

179,241


104,253


283,494


141,531




THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS (REGISTERED NUMBER: 09672970)



BALANCE SHEET

31 DECEMBER 2025



2025


2024


Unrestricted


Restricted


Total


Total


funds


funds


funds


funds


Notes

£   

£   

£   

£   


CURRENT ASSETS


Debtors

8

61,673


-


61,673


20,155


Cash at bank

228,790


104,253


333,043


214,560


290,463


104,253


394,716


234,715



CREDITORS


Amounts falling due within one year

9

(111,222

)

-


(111,222

)

(93,184

)


NET CURRENT ASSETS

179,241


104,253


283,494


141,531



TOTAL ASSETS LESS CURRENT

LIABILITIES

179,241


104,253


283,494


141,531



NET ASSETS

179,241


104,253


283,494


141,531


FUNDS

10

Unrestricted funds

179,241


84,034


Restricted funds

104,253


57,497


TOTAL FUNDS

283,494


141,531



The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.


The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.



THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS (REGISTERED NUMBER: 09672970)



BALANCE SHEET - continued

31 DECEMBER 2025


These financial statements have been prepared in accordance with and delivered in accordance with the special provisions applicable to small charitable companies subject to the small companies regime.



The financial statements were approved by the Board of Trustees and authorised for issue on 9 July 2026  and were signed on its behalf by:






P P Davies - Trustee






A F C Collier BEM - Trustee



THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025



1.

ACCOUNTING POLICIES



Basis of preparing the financial statements


The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.



Income


All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.



Expenditure


Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.



Employee benefits


The cost of short-term employee benefits are recognised as a liability and an expense. The cost of any material unused holiday entitlement is recognised in the period in which the employee's services are received.



Taxation

The charity is exempt from corporation tax on its charitable activities.


Fund accounting

General funds - these are unrestricted funds which can be used for the charitable objects at the discretion of the Trustees and which have not been designated for other purposes.

Restricted funds - these are funds that can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Designated funds - these are unrestricted funds which have been set aside by the Trustees for specific purposes. The aim and use of each designated fund is set out in notes to the financial statements.


Interest receivable

Interest on funds held on deposit is included when receivable; this is normally upon receipt or upon notification of the interest paid by the Bank or Building Society.


Pension costs and other post-retirement benefits


The charitable company operates a defined contribution stakeholder pension scheme. The amount charged to the statement of financial activities in respect of pension costs is the Charity's contributions payable in the year. The assets of the scheme are held separately from the Charity. There was no outstanding liability owed to the scheme at the end of the current or prior years.




THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 DECEMBER 2025



1.

ACCOUNTING POLICIES - continued



Financial instruments

Basic financial assets, which include cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

2.

INVESTMENT INCOME


2025


2024

£   

£   



Deposit account interest

6,492


595




3.

CHARITABLE ACTIVITIES COSTS


Direct


Costs (see


note 4)

£   



Charitable activities

249,392




4.

DIRECT COSTS OF CHARITABLE ACTIVITIES


2025


2024

£   

£   



Staff costs

117,168


80,389




Recruitment

-


1,202




Training

1,136


-




Consultancy

1,125


-




Campaigning and awareness

38,462


20,830




Groups support

10,086


10,626




Other costs

80,695


63,118




Legal and professional fees

720


472



249,392


176,637




5.

TRUSTEES' REMUNERATION AND BENEFITS



Trustees' expenses



The key management personnel of the Charity are the Trustees who do not receive remuneration but during the year the charity paid aggregate expenses totalling £2,690 (2024: £1,479) relating to 9 (2024: 5) trustees in respect of travel, accommodation and subsistence.



The charity includes Trustees' Liability Insurance in its combined insurance policy.




THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 DECEMBER 2025



6.

STAFF COSTS


2025


2024

£   

£   



Wages and salaries

111,821


76,060




Social security costs

2,990


2,570




Other pension costs

2,357


1,759



117,168


80,389





The average monthly number of employees during the year was as follows:



2025


2024


Engagement

3


3





No employees received emoluments in excess of £60,000.


7.

COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES


Unrestricted


Restricted


Total


funds


funds


funds

£   

£   

£   



INCOME AND ENDOWMENTS FROM


Donations and legacies

76,255


102,378


178,633




Investment income

595


-


595



Total

76,850


102,378


179,228




EXPENDITURE ON


Raising funds

25,049


103


25,152




Charitable activities


Charitable activities

90,071


86,566


176,637



Total

115,120


86,669


201,789




NET INCOME/(EXPENDITURE)

(38,270

)

15,709


(22,561

)


Transfers between funds

7,269


(7,269

)

-



Net movement in funds

(31,001

)

8,440


(22,561

)



RECONCILIATION OF FUNDS


Total funds brought forward

115,035


49,057


164,092




TOTAL FUNDS CARRIED FORWARD

84,034


57,497


141,531





THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 DECEMBER 2025



8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024


£   

£   



Trade debtors

51,206


13,539




Accrued income

3,124


1,750




Prepayments

7,343


4,866



61,673


20,155




9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024


£   

£   



Trade creditors

6,659


5,409




Social security and other taxes

2,102


4,687




Other creditors

523


133




Accruals

1,192


1,028




Deferred income

100,746


81,927



111,222


93,184




10.

MOVEMENT IN FUNDS


Net


Transfers




movement


between


At



At 1.1.25


in funds


funds


31.12.25


£   

£   

£   

£   



Unrestricted funds


General

59,034


48,946


46,261


154,241




Designated - Development Fund

25,000


-


-


25,000



84,034


48,946


46,261


179,241




Restricted funds


Tacking Prostate Cancer - peer to peer

support for men with prostate cancer

47,941


38,628


(60,699

)

25,870




Other restricted funds

9,556


39,934


(10,920

)

38,570




West Midlands Community Fund

-


3,055


25,358


28,413




Peer Coaching Communications

-


11,400


-


11,400



57,497


93,017


(46,261

)

104,253




TOTAL FUNDS

141,531


141,963


-


283,494





THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 DECEMBER 2025



10.

MOVEMENT IN FUNDS - continued



Net movement in funds, included in the above are as follows:



Incoming


Resources


Movement



resources


expended


in funds


£   

£   

£   



Unrestricted funds


General

137,294


(88,348

)

48,946





Restricted funds


Tacking Prostate Cancer - peer to peer

support for men with prostate cancer

157,837


(119,209

)

38,628




Other restricted funds

108,296


(68,362

)

39,934




West Midlands Community Fund

5,000


(1,945

)

3,055




Peer Coaching Communications

12,000


(600

)

11,400



283,133


(190,116

)

93,017




TOTAL FUNDS

420,427


(278,464

)

141,963






Comparatives for movement in funds



Net


Transfers




movement


between


At



At 1.1.24


in funds


funds


31.12.24


£   

£   

£   

£   



Unrestricted funds


General

90,035


(38,270

)

7,269


59,034




Designated - Development Fund

25,000


-


-


25,000



115,035


(38,270

)

7,269


84,034




Restricted funds


Tackle Man Van

2,500


-


(2,500

)

-




Tacking Prostate Cancer - peer to peer

support for men with prostate cancer

14,596


33,345


-


47,941




Other restricted funds

31,961


(17,636

)

(4,769

)

9,556



49,057


15,709


(7,269

)

57,497




TOTAL FUNDS

164,092


(22,561

)

-


141,531





THE NATIONAL FEDERATION OF PROSTATE



CANCER SUPPORT GROUPS



NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 DECEMBER 2025



10.

MOVEMENT IN FUNDS - continued



Comparative net movement in funds, included in the above are as follows:



Incoming


Resources


Movement



resources


expended


in funds


£   

£   

£   



Unrestricted funds


General

76,850


(115,120

)

(38,270

)




Restricted funds


Tacking Prostate Cancer - peer to peer

support for men with prostate cancer

95,378


(62,033

)

33,345




Other restricted funds

7,000


(24,636

)

(17,636

)


102,378


(86,669

)

15,709




TOTAL FUNDS

179,228


(201,789

)

(22,561

)



11.

RELATED PARTY DISCLOSURES



There were no related party transactions for the year ended 31 December 2025.